機能的内視鏡副鼻腔手術の世界市場

機能的内視鏡副鼻腔手術の世界市場は2030年までに18億米ドルに達する

2024年に12億米ドルと推定される機能的内視鏡副鼻腔手術の世界市場は、2024年から2030年にかけてCAGR 5.9％で成長し、2030年には18億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである顎骨処置は、CAGR 4.9％を記録し、分析期間終了までに11億米ドルに達すると予想されています。篩骨処置セグメントの成長率は、分析期間でCAGR 7.7％と推定されます。

米国市場は3億3,900万米ドルと推定、中国はCAGR9.2％で成長予測

米国の機能的内視鏡副鼻腔手術市場は、2024年に3億3,900万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.2%で推移し、2030年には3億5,370万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0％と5.8％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の「機能的内視鏡副鼻腔手術（FESS）」市場- 主要動向と促進要因まとめ

なぜFESSは慢性副鼻腔疾患に対する望ましいアプローチになりつつあるのか？

機能的内視鏡副鼻腔手術（FESS）は、慢性鼻副鼻腔炎、鼻ポリープ、その他の副鼻腔病変を治療するための標準的な治療法として急速に脚光を浴び、従来の侵襲的な方法に代わって、低侵襲で精度の高い技術が用いられています。FESSの人気は、健康な組織を傷つけることなく、副鼻腔の換気と排液を正常に戻すことができることに起因しています。高解像度の内視鏡とマイクロ器具を使用し、鼻孔から副鼻腔にアクセスするため、外からの切開の必要性が大幅に減少し、回復が早まる。耳鼻咽喉科専門医は、術後合併症の減少、入院期間の短縮、長期的な治療成績の向上から、FESSを好んでいます。世界の慢性副鼻腔炎の罹患率の上昇は、公害、アレルギー、都市部のライフスタイル、耐性菌感染などに起因しており、患者層は拡大しています。手術ナビゲーション、リアルタイム画像、3D内視鏡による可視化などの技術の進歩により、FESSはこれまで以上に安全で正確なものとなっています。より多くの患者が、より低侵襲で回復時間の早い解決策を求めるようになり、また支払者が価値ベースのケアに傾くにつれて、FESSは専門医の選択肢から、公立・私立両方のヘルスケアシステムの耳鼻咽喉科で広く採用される外科的標準へと進化しつつあります。

ツールと画像の革新は、手術の精度をどのように高めているか？

FESSの進化は、手術技術の進歩、特に画像診断、ナビゲーション、器具の小型化と深く結びついています。画像誘導手術（IGS）システムは現在、術前のCTやMRIスキャンを用いたリアルタイムのナビゲーションを可能にし、眼窩や脳などの隣接構造を損傷するリスクを大幅に低減しています。4Kおよび3D可視化機能を備えた高度な内視鏡は、比類のない鮮明さと奥行き感を提供し、外科医の狭い解剖学的経路での操作能力を向上させる。マイクロデブリッダーや高周波プローブなどの電動器具は、組織選択的切除のために最適化されており、最小限の外傷で炎症組織や閉塞組織をより制御された形で除去することができます。バルーン副鼻腔形成術は、しばしばFESSの補完的あるいは前駆的な治療法と考えられているが、より軽症の症例では、手術室の負担を軽減する、診察室ベースの非侵襲的な治療法として普及しています。止血材、生体吸収性ステント、術後薬剤溶出性インプラントなどの技術革新は、術後の治癒を改善し、再手術率を低下させています。さらに、解剖学的に複雑な症例や再手術症例における高精度の手技のために、ロボットによる補助が検討されています。このような技術的飛躍的進歩により、FESSはより予測可能で再現性が高くなり、さまざまな病院や外来治療の場で利用しやすくなっています。

どのような患者層と臨床動向が需要を牽引しているか？

FESSに対する需要の高まりは、患者層や臨床ケアモデルの変化に大きく影響されています。慢性副鼻腔炎は世界人口の10％以上が罹患しており、生活の質、仕事の生産性、ヘルスケアコストに大きな影響を与える疾患として認識されつつあります。罹患率が最も高いのは中高年で、特に大気汚染やアレルゲンへの曝露が多い都市部や工業地帯に多いです。しかし、安全性と回復のプロファイルが改善されるにつれて、小児や老年期の患者が内視鏡的方法で治療を受ける傾向が高まっています。アレルギー性鼻炎、喘息、HIVや糖尿病などの免疫不全疾患の世界の増加も、副鼻腔疾患有病率の増加に寄与しています。副鼻腔手術歴のある患者は、成功率が高く合併症が少ないことから、再手術を選択することが多くなっています。医療提供者の立場から見ると、耳鼻咽喉科クリニックや外来手術センターは、その収益を生み出す可能性、日帰り手術に対する患者の嗜好、術前タイミングの短縮などの理由から、FESSを提供することが多くなっています。COVID後に選択手術の件数が回復するにつれて、FESSはその臨床的緊急性と症状緩和の可能性から、予定が急速に回復している手術の一つです。

機能的内視鏡副鼻腔手術市場の成長はいくつかの要因によってもたらされる

機能的内視鏡副鼻腔手術（FESS）市場の成長は、臨床の進歩、患者の需要、医療システムの優先順位に関連するいくつかの要因によってもたらされます。第一に、慢性鼻副鼻腔炎、鼻閉、アレルギー性ポリポーシスの診断が増加し、手術対象者が拡大しています。第2に、画像診断、ナビゲーション、電動器具の技術的進歩により、合併症を最小限に抑えながら手術の成功率が向上しています。第3に、外来患者や低侵襲手術の推進が、ヘルスケア施設に従来のアプローチよりもFESSを優先するよう促しています。第4に、好意的な償還政策と総治療費の削減が、医療提供者と支払者双方にとってFESSをより魅力的なものにしています。第5に、副鼻腔の健康や未治療の感染症のリスクに関する世界の啓発キャンペーンが、患者が早期に専門医の診察を受けるよう促し、手術の転換率を高めています。最後に、バンドル手術キット、術後ケア機器、副鼻腔専用インプラントの出現により、耳鼻咽喉科医はFESSのワークフローを合理化できるようになり、FESSは臨床的な解決策であるだけでなく、現代の耳鼻咽喉科において手術効率の高い治療法となっています。

セグメント

手技（上顎手技、篩骨手技）;適応症（慢性副鼻腔炎適応症、鼻ポリープ症適応症）;エンドユース（病院エンドユース、外来手術センターエンドユース、専門クリニックエンドユース）

調査対象企業の例（注目の32社）

• Acclarent, Inc.
• Adept Medical
• Advin Health Care
• Atmos MedizinTechnik GmbH & Co. KG
• B. Braun Melsungen AG
• Brainlab AG
• ClaroNav
• Collin Medical
• Conmed Corporation
• Ecleris
• Entermed
• Fiagon GmbH
• Grace Medical, Inc.
• Heal Force Bio-Meditech Holdings Ltd.
• Henke Sass Wolf GmbH
• Innovia Medical
• Integra LifeSciences
• Intersect ENT, Inc.
• Johnson & Johnson（Ethicon, Inc.）
• Karl Storz GmbH & Co. KG

AI統合

私たちは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Functional Endoscopic Sinus Surgery Market to Reach US$1.8 Billion by 2030

The global market for Functional Endoscopic Sinus Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Maxillary Procedure, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Ethmoid Procedure segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$339.0 Million While China is Forecast to Grow at 9.2% CAGR

The Functional Endoscopic Sinus Surgery market in the U.S. is estimated at US$339.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$353.7 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global "Functional Endoscopic Sinus Surgery (FESS)" Market - Key Trends & Drivers Summarized

Why Is FESS Becoming the Preferred Approach for Chronic Sinus Conditions?

Functional Endoscopic Sinus Surgery (FESS) has rapidly gained prominence as the standard of care for treating chronic rhinosinusitis, nasal polyps, and other sinus pathologies, replacing traditional invasive methods with a minimally invasive, precision-based technique. The popularity of FESS stems from its ability to restore normal sinus ventilation and drainage without damaging healthy tissues. It employs high-definition endoscopes and micro-instruments to access sinus cavities through the nostrils, significantly reducing the need for external incisions and promoting faster recovery. ENT specialists prefer FESS due to reduced postoperative complications, shorter hospital stays, and better long-term outcomes. The rising incidence of chronic sinusitis globally-driven by pollution, allergies, urban lifestyles, and resistant bacterial infections-has expanded the patient base. Technological advances in surgical navigation, real-time imaging, and 3D endoscopic visualization have made FESS safer and more accurate than ever before. As more patients demand less invasive solutions with faster recovery times, and as payers lean toward value-based care, FESS is evolving from a specialist option to a widely adopted surgical norm in otolaryngology departments across both public and private healthcare systems.

How Are Innovations in Tools and Imaging Enhancing Surgical Precision?

The evolution of FESS is deeply tied to the progress of surgical technology, particularly in imaging, navigation, and instrument miniaturization. Image-guided surgery (IGS) systems now allow real-time navigation using preoperative CT or MRI scans, significantly reducing the risk of damaging adjacent structures such as the orbit or brain. Advanced endoscopes with 4K and 3D visualization offer unparalleled clarity and depth perception, enhancing surgeons’ ability to maneuver in narrow anatomical pathways. Powered instruments like microdebriders and radiofrequency probes are being optimized for tissue-selective resection, allowing more controlled removal of inflamed or obstructive tissue with minimal trauma. Balloon sinuplasty-often considered a complement or precursor to FESS-is also gaining traction for milder cases, offering office-based, non-invasive alternatives that reduce the burden on operating rooms. Innovations in hemostatic materials, bioabsorbable stents, and post-op drug-eluting implants are improving postoperative healing and reducing revision rates. Additionally, robotic assistance is being explored for high-precision procedures in anatomically complex or revision cases. These technological breakthroughs are making FESS more predictable, reproducible, and accessible across a range of hospital and ambulatory care settings.

Which Patient Demographics and Clinical Trends Are Driving Demand?

The growing demand for FESS is largely influenced by shifting patient demographics and clinical care models. Chronic sinusitis affects over 10% of the global population and is increasingly recognized as a condition that significantly impacts quality of life, work productivity, and healthcare costs. The highest incidence is seen in middle-aged adults, particularly in urban and industrial regions with high air pollution and allergen exposure. However, there’s a growing trend of pediatric and geriatric patients being treated via endoscopic methods as safety and recovery profiles improve. The global rise in allergic rhinitis, asthma, and immunocompromised conditions such as HIV and diabetes has also contributed to increased sinus disease prevalence. Patients with prior sinus surgeries are now more frequently opting for revision FESS due to better success rates and low complication profiles. From a provider standpoint, ENT clinics and outpatient surgical centers are increasingly offering FESS due to its revenue-generating potential, patient preference for day surgeries, and shorter preoperative timelines. As elective surgery volumes recover post-COVID, FESS is among the procedures seeing rapid scheduling rebounds due to its clinical urgency and symptom relief potential.

The Growth in the Functional Endoscopic Sinus Surgery Market Is Driven by Several Factors

The growth in the functional endoscopic sinus surgery (FESS) market is driven by several factors related to clinical advancements, patient demand, and health system priorities. First, increased diagnosis of chronic rhinosinusitis, nasal obstructions, and allergic polyposis is expanding the eligible surgical population. Second, technological progress in imaging, navigation, and powered instrumentation is enhancing procedure success rates while minimizing complications. Third, the push for outpatient and minimally invasive procedures is encouraging healthcare facilities to prioritize FESS over conventional approaches. Fourth, favorable reimbursement policies and reduced total cost of care are making it more appealing to providers and payers alike. Fifth, global awareness campaigns around sinus health and the risks of untreated infections are pushing patients to seek specialist consultations earlier, increasing procedural conversion rates. Finally, the emergence of bundled surgical kits, post-op care devices, and sinus-specific implantables is enabling ENT surgeons to streamline FESS workflows-making it not just a clinical solution, but also an operationally efficient offering within modern otolaryngology.

SCOPE OF STUDY:

The report analyzes the Functional Endoscopic Sinus Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure (Maxillary Procedure, Ethmoid Procedure); Indication (Chronic Sinusitis Indication, Nasal Polyposis Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Acclarent, Inc.
• Adept Medical
• Advin Health Care
• Atmos MedizinTechnik GmbH & Co. KG
• B. Braun Melsungen AG
• Brainlab AG
• ClaroNav
• Collin Medical
• Conmed Corporation
• Ecleris
• Entermed
• Fiagon GmbH
• Grace Medical, Inc.
• Heal Force Bio-Meditech Holdings Ltd.
• Henke Sass Wolf GmbH
• Innovia Medical
• Integra LifeSciences
• Intersect ENT, Inc.
• Johnson & Johnson (Ethicon, Inc.)
• Karl Storz GmbH & Co. KG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Functional Endoscopic Sinus Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Sinusitis Drives Demand for Advanced FESS Procedures
  • Technological Innovations in Endoscopic Instruments Propel Adoption of Minimally Invasive Techniques
  • Growth in Ambulatory Surgical Centers Expands Accessibility of Functional Sinus Surgeries
  • Improved Patient Outcomes and Reduced Recovery Times Strengthen Business Case for FESS
  • Increasing ENT Specialist Adoption of Image-Guided Navigation Systems Enhances Procedural Precision
  • Healthcare Reimbursement Reforms Accelerate Uptake of Functional Sinus Interventions
  • Advancements in Balloon Sinuplasty and 3D Visualization Tools Expand Market Penetration
  • Focus on Patient-Centric Care Models Throws Spotlight on Daycare Endoscopic Procedures
  • Rising Awareness of Allergic Rhinitis and Nasal Disorders Sustains Procedural Demand
  • Training and Certification Programs Enhance Surgeon Readiness and Broaden FESS Adoption
  • Integration of AI and Robotics in ENT Surgeries Spurs Innovation in FESS Market
  • Global Medical Tourism Trends Generate Cross-Border Demand for Cost-Effective FESS Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Functional Endoscopic Sinus Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Maxillary Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Maxillary Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Maxillary Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ethmoid Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ethmoid Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Ethmoid Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Chronic Sinusitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Chronic Sinusitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Chronic Sinusitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Nasal Polyposis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Nasal Polyposis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Nasal Polyposis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION